These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29719371)

  • 61. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The goals and functions of a P & T committee.
    Sudds TW; Williams RR
    Hosp Formul; 1985 Nov; 20(11):1163-5, 1171, 1174. PubMed ID: 10274572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice.
    Lozano-Blázquez A; Calvo-Pita C; Carbajales-Álvarez M; Suárez-Gil P; Martínez-Martínez F; Calleja-Hernández MÁ
    Ther Clin Risk Manag; 2014; 10():527-35. PubMed ID: 25031538
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A PROCESS OF PRIORITIZING TOPICS FOR HEALTH TECHNOLOGY ASSESSMENT IN KAZAKHSTAN.
    Kosherbayeva L; Hailey D; Kurakbaev K; Tabarov A; Kumar A; Gutzskaya G; Stepkina E
    Int J Technol Assess Health Care; 2016 Jan; 32(3):147-51. PubMed ID: 27502426
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Priority setting for health technology assessment at CADTH.
    Husereau D; Boucher M; Noorani H
    Int J Technol Assess Health Care; 2010 Jul; 26(3):341-7. PubMed ID: 20584365
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Weighing the evidence: trends in managed care formulary decision making.
    de Lissovoy G
    J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The System of Objectified Judgement Analysis (SOJA). A tool in rational drug selection for formulary inclusion.
    Janknegt R; Steenhoek A
    Drugs; 1997 Apr; 53(4):550-62. PubMed ID: 9098659
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The formulary decision-making process in a health maintenance organisation setting.
    Shepherd MD; Salzman RD
    Pharmacoeconomics; 1994 Jan; 5(1):29-38. PubMed ID: 10146864
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factors that influence prescribing decisions.
    Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK
    Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acceptance of a pharmacy-based, physician-edited hospital pharmacy and therapeutics committee newsletter.
    Ritchie DJ; Manchester RF; Rich MW; Rockwell MM; Stein PM
    Ann Pharmacother; 1992; 26(7-8):886-9. PubMed ID: 1504393
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Methods for the comparative evaluation of pharmaceuticals.
    Zentner A; Velasco-Garrido M; Busse R
    GMS Health Technol Assess; 2005 Nov; 1():Doc09. PubMed ID: 21289930
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of multiattribute utility theory for formulary management in a health system.
    Chung S; Kim S; Kim J; Sohn K
    Am J Health Syst Pharm; 2010 Jan; 67(2):128-35. PubMed ID: 20065267
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Incorporation of a mock pharmacy and therapeutics committee as an entrustable professional activity supporting task.
    Borja-Hart NL; Rowe AS; Gatwood J; Wheeler J
    Curr Pharm Teach Learn; 2021 Jul; 13(7):784-788. PubMed ID: 34074508
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacy formularies in integrated health systems.
    Osborne JA
    J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.